Jay Olson

Aug 05, 2026

Jay Olson rated AMGN as Outperform on Aug 05, 2026, setting a price target of 450. The stock has underperformed, dropping 7.47% despite the bullish target of 450.

Jul 28, 2026

On Jul 28, 2026, FTH was given a Outperform rating by Jay Olson, with a target price of 60. The stock rallied 28.53% after the rating, narrowing the gap to the target of 60 and validating the bullish stance.

Jul 13, 2026

QTTB received a Outperform rating from Jay Olson on Jul 13, 2026, aiming for 40. The rating hasn’t played out as hoped, with the stock trading 48.08% below expectations.

Jul 07, 2026

On Jul 07, 2026, Jay Olson published a Outperform outlook on KYNB, with a target of 35. Shares gained 5.70%, underscoring the accuracy of the bullish outlook toward 35.

Jun 26, 2026

Jay Olson on Jun 26, 2026 assigned EPRX a Outperform rating, with a price target of 17. The Buy call aligned well with market performance, producing a gain of 27.58%.

Jun 22, 2026

On Jun 22, 2026, Jay Olson reaffirmed DFTX with a Outperform rating, targeting 60. The recommendation was supported by strong follow-through as the stock rose from 38.89 to 38.89.

Jun 02, 2026

PRAX was rated Outperform by Jay Olson on Jun 02, 2026, with a price objective of 650. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Jun 01, 2026

On Jun 01, 2026, Jay Olson initiated coverage on RVMD with a Outperform rating and target of 195. The stock’s climb of 24.49% since the call highlights the foresight in the rating.

May 28, 2026

Jay Olson issued a Outperform recommendation for ANL on May 28, 2026, price target set at 32. Investors following the Buy call captured upside momentum, with shares now at 15.21.

Apr 21, 2026

Jay Olson rated PASG as Outperform on Apr 21, 2026, setting a price target of 15. The stock has underperformed, dropping 19.09% despite the bullish target of 15.

Apr 01, 2026

On Apr 01, 2026, BIIB was given a Outperform rating by Jay Olson, with a target price of 275. The stock rallied 18.16% after the rating, narrowing the gap to the target of 275 and validating the bullish stance.

Mar 18, 2026

BCYC received a Outperform rating from Jay Olson on Mar 18, 2026, aiming for 36. The rating hasn’t played out as hoped, with the stock trading 17.87% below expectations.

Mar 10, 2026

On Mar 10, 2026, Jay Olson published a Outperform outlook on VRTX, with a target of 600. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 515.44.

Feb 25, 2026

Jay Olson on Feb 25, 2026 assigned BIOA a Outperform rating, with a price target of 60. The call has struggled to gain traction, with shares losing 61.65%.

Jan 22, 2026

CHRS was rated Outperform by Jay Olson on Jan 22, 2026, with a price objective of 10. This case shows how bullish projections can fail, with the stock now below 1.33.

Dec 09, 2025

On Dec 09, 2025, Jay Olson initiated coverage on TERN with a Outperform rating and target of 58. The stock’s climb of 24.38% since the call highlights the foresight in the rating.

Nov 20, 2025

Jay Olson issued a Outperform recommendation for MDGL on Nov 20, 2025, price target set at 650. The target of 650 remains in play, though confirmation will depend on future moves.

Oct 21, 2025

On Oct 21, 2025, IBIO was evaluated by Jay Olson, who gave a Outperform rating and target of 5. This case illustrates how a timely bullish rating can translate into tangible gains of 8.56%.

Oct 08, 2025

Jay Olson rated IONS as Outperform on Oct 08, 2025, setting a price target of 90. The stock has underperformed, dropping 22.51% despite the bullish target of 90.

Sep 25, 2025

On Sep 25, 2025, IMRX was given a Outperform rating by Jay Olson, with a target price of 30. Despite the Buy call, shares fell from 4.27 to 4.27, challenging the optimistic stance.

Aug 04, 2025

MNMD received a Outperform rating from Jay Olson on Aug 04, 2025, aiming for 25. Momentum has favored the Buy call, with shares climbing from 20.69 to 20.69, rewarding those who trusted the recommendation.

Jul 29, 2025

On Jul 29, 2025, Jay Olson published a Outperform outlook on ATAI, with a target of 14. Shares gained 122.05%, underscoring the accuracy of the bullish outlook toward 14.

May 15, 2025

On May 15, 2025, Jay Olson reaffirmed JSPR with a Outperform rating, targeting 65. Shares slid 86.44% despite the recommendation, highlighting downside risks.

Mar 14, 2025

NKTR was rated Outperform by Jay Olson on Mar 14, 2025, with a price objective of 6. A bullish response from the market helped close the gap of -63.76 to the target.

Mar 03, 2025

On Mar 03, 2025, Jay Olson initiated coverage on DNLI with a Outperform rating and target of 42. The stock’s climb of 38.75% since the call highlights the foresight in the rating.

Jan 13, 2025

On Jan 13, 2025, NTLA was evaluated by Jay Olson, who gave a Outperform rating and target of 40. This case illustrates how a timely bullish rating can translate into tangible gains of 16.82%.

Dec 06, 2024

Jay Olson rated SGMT as Outperform on Dec 06, 2024, setting a price target of 30. The call has proven timely, with shares rising 113.33% toward the price target of 30.

Nov 18, 2024

On Nov 18, 2024, INO was given a Outperform rating by Jay Olson, with a target price of 15. Despite the Buy call, shares fell from 1.25 to 1.25, challenging the optimistic stance.

Oct 17, 2024

GLTO received a Outperform rating from Jay Olson on Oct 17, 2024, aiming for 10. Momentum has favored the Buy call, with shares climbing from 21.58 to 21.58, rewarding those who trusted the recommendation.

Sep 25, 2024

On Sep 25, 2024, Jay Olson published a Outperform outlook on VKTX, with a target of 138. Market action contradicted the Buy thesis, as shares slipped to 31.98.

Sep 23, 2024

Jay Olson on Sep 23, 2024 assigned MRNS a Outperform rating, with a price target of 6. The call has struggled to gain traction, with shares losing 66.26%.

Aug 14, 2024

On Aug 14, 2024, Jay Olson reaffirmed GANX with a Outperform rating, targeting 8. The recommendation was supported by strong follow-through as the stock rose from 1.75 to 1.75.

Aug 02, 2024

NBIX was rated Outperform by Jay Olson on Aug 02, 2024, with a price objective of 219. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

May 10, 2024

Jay Olson issued a Outperform recommendation for CRSP on May 10, 2024, price target set at 95. The target of 95 remains in play, though confirmation will depend on future moves.